Stockreport

CervoMed to Participate in the BIO CEO and Investor Conference

CervoMed Inc.  (CRVO) 
PDF BOSTON, Feb. 21, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for degenerative diseases of the brai [Read more]